Company / Working Capital
Solventum Working Capital History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$723.0M
FY2025
5-year range
$546.0M / $791.0M
FY2023-FY2025
Trend
+32.4%
vs FY2024
Sector context
#47 of 160
Health Care
What the data says
At $723M, Solventum's working capital ranks #47 of 160 in the Health Care sector. Declined from $791M to $723M over the past 2 years.
Based on SEC 10-K filings.
$723M in FY2025.
Declined from $791M to $723M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#47 of 160 in Health CareTop 29% of 160This company $723.0M Sector average $757.1M
▼
-4.5% below sector average
Key checks
Key Insights
- In FY2025, working capital increased 32.4% year-over-year.
- Ranks #47 out of 160 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $723.0M | +32.4% |
| FY2024 | $546.0M | -31.0% |
| FY2023 | $791.0M | - |
| FY2022 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026